Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Capital Expenditures: 2019-2025

Historic Capital Expenditures for Eton Pharmaceuticals (ETON) over the last 3 years, with Sep 2025 value amounting to $284,000.

  • Eton Pharmaceuticals' Capital Expenditures was N/A to $284,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $322,000, marking a year-over-year change of. This contributed to the annual value of $26,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Capital Expenditures is $284,000, which was up 2,266.67% from $12,000 recorded in Q4 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Capital Expenditures peaked at $284,000 during Q3 2025, and registered a low of $2,000 during Q3 2021.
  • Over the past 2 years, Eton Pharmaceuticals' median Capital Expenditures value was $14,000 (recorded in 2024), while the average stood at $103,333.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 90.91% in 2021, then soared by 200.00% in 2022.
  • Quarterly analysis of 4 years shows Eton Pharmaceuticals' Capital Expenditures stood at $4,000 in 2021, then skyrocketed by 200.00% to $12,000 in 2022, then reached $12,000 in 2024, then reached $284,000 in 2025.
  • Its last three reported values are $284,000 in Q3 2025, $12,000 for Q4 2024, and $14,000 during Q1 2024.